ArticleInflammopharmacology2025
Nuclear receptor 4A1 inhibits chondrocyte inflammation and cartilage degeneration in osteoarthritis by inhibiting NF-κB signal pathway.
Article in Inflammopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- [Advances in immunomodulatory strategies for meniscal regeneration].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2026Review
- PSMB9 exacerbates chondrocyte injury in osteoarthritis via activation of the NF-κB pathway.Journal of orthopaedic surgery and research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe objective of this study is to explore the mechanism of nuclear receptor subfamily 4 group A member 1 (NR4A1) inhibiting the inflammatory response and cartilage degeneration of osteoarthritis (OA) chondrocytes by inhibiting the nuclear factor κB (NF-κB).
methodsA total of 45 Sprague-Dawley (SD) rats were randomly divided into three groups (n = 15 in each group): the blank control group (BCG), OA model group (OAG), and NR4A1 overexpression group (OE-NR4A1). The rat model of knee OA was established by medial meniscectomy. A total of 1 week after the operation, the rat model of NR4A1 overexpression was established by injecting NR4A1 overexpression lentivirus into the articular cavity of rats; 5 weeks after the establishment of the model, the rats were killed, and the morphological changes of knee cartilage were observed by hematoxylin and eosin (HE) staining under light microscope. The expression of NR4A1 and NF-κB protein in cartilage tissue was detected by western blot, and the relative expression of NR4A1 and NF-κB mRNA in cartilage tissue was detected by real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR). The levels of interleukin (IL)-6, IL-8 and tumor necrosis factor (TNF)-α in the supernatant of chondrocytes were detected by ELISA, and the apoptosis of chondrocytes was detected by TUNEL staining.
resultsThe relative expression of NR4A1 mRNA and protein in knee cartilage of rats in OE-NR4A1 were raised compared with those of OAG and BCG (P < 0.05). The relative expression of NF-κB mRNA and protein expression in knee joint cartilage in OE-NR4A1 were reduced compared with those of OAG and BCG, while their expression in the OE-NR4A1 (200 μL) and OE-NR4A1 (300 μL) groups were lower than in the OE-NR4A1 (100 μL) group(P < 0.05). The knee cartilage Mankin's score and knee joint diameter in the OAG were raised compared with those in the BCG (P < 0.05), while those in the OE-NR4A1 were reduced compared with the OAG (P < 0.05), but higher than in the BCG; these measures in the OE-NR4A1 (200 μL) and OE-NR4A1 (300 μL) groups were lower than in the OE-NR4A1 (100 μL) group (P < 0.05). The levels of IL-6, TNF-α, and IL-1β in knee synovial fluid of rats in OE-NR4A1 were reduced compared with those in the OAG (P < 0.05), but raised compared with those in the BCG; and these in the OE-NR4A1 (200 μL) and OE-NR4A1 (300 μL) groups were lower than in the OE-NR4A1 (100 μL) group (P < 0.05). The scorch rate of chondrocytes in the OE-NR4A1 was reduced compared with that in the OAG and higher than that of the BCG, and this measure in the OE-NR4A1 (200 μL) and OE-NR4A1 (300 μL) groups was lower than in the OE-NR4A1 (100 μL) group (P < 0.05).
conclusionsR4A1 can improve the level of intraarticular inflammatory factors by inhibiting the NF-κB signal pathway, thereby reducing intraarticular inflammation and cartilage degeneration, and it plays a protective role in OA.
Indexed as
Identifiers
39964671What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.